The Office of Cancer Clinical Proteomics Research announced today its multi-institutional program to further the convergence of proteomics with genomics, or “proteogenomics,” to better understand the ...
Explore how clinical multi-omics integration drives systems medicine, detailing data fusion methodologies and lab ...
Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
REDWOOD CITY, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new Proteogenomics ...
Using an approach that includes integrating proteomics, genomics, and epigenomics data from 10 cancer types, researchers at the Baylor College of Medicine and collaborating institutions have ...
Researchers at Baylor College of Medicine, the Broad Institute of MIT and Harvard and other institutions have applied powerful proteogenomics approaches to better understand the biological complexity ...
Mary F. Lopez, Ph.D. Learn how a proteogenomics approach can improve your investigational power. Combining genomic and proteomic techniques can reveal important insights to unlock complex biological ...
Proteogenomics and their applications in target cancer therapy research. The application of proteogenomics (mainly including genomics, transcriptomics, and proteomics) has become an indispensable tool ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results